September 4, 2015
Not for distribution, directly or indirectly, in or into the United States, Australia, Canada or Japan

Bayer plans IPO for Covestro more

September 1, 2015
Former Bayer MaterialScience now legally and economically independent

Covestro up and running more

September 1, 2015
Not intended for U.S. and UK Media - Late-Breaking Science at ESC Congress 2015:

New Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer’s Xarelto® in Patients with Non-Valvular Atrial Fibrillation more

News Overview

Bayer Group

Bayer MaterialScience with New Identity

Bayer MaterialScience is now independent under the name Covestro. Bayer intends to float Covestro on the stock market by mid-2016 at the latest.


Bayer Group – Video

Bayer Becomes a Pure Life Science Company

With our extensive experience in science and innovation we’re committed to improving human, animal and plant health. more


Select product


Select division


Select country
Last updated: September 4, 2015 Copyright © Bayer AG